Trial record 1 of 1 for:    NCT02114229
Previous Study | Return to List | Next Study

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors (SJATRT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02114229
Recruitment Status : Recruiting
First Posted : April 15, 2014
Last Update Posted : December 13, 2018
Millennium Pharmaceuticals, Inc.
Takeda Pharmaceuticals U.S.A., Inc.
Information provided by (Responsible Party):
St. Jude Children's Research Hospital

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2023
  Estimated Study Completion Date : May 2027